Roswell Park Cancer Institute receives “outstanding” distinction from NCI

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

ROSWELL PARK CANCER INSTITUTE received an “outstanding” distinction from NCI, which renewed its Cancer Center Support Grant and extended its Comprehensive Cancer Center designation, following an in-depth peer review. Roswell Park will receive $19 million with the core grant covering a five-year period.

“With this renewal comes recognition from our peers from cancer centers around the nation of Roswell Park’s excellence in conducting innovative research, distinguished education programs and exemplary patient care,” said RPCI President and CEO Donald Trump.

The panel of peer reviewers from other NCI-designated centers wrote: “Under the exemplary leadership of the Center Director and with the continued involvement of the outstanding and productive Senior Leaders and commitment of the Institution… this established Cancer Center is well positioned to continue its contributions to the national mission to understand and eliminate cancer.”

New York State Governor Andrew Cuomo and Congressman Brian Higgins, along with other state and local leaders, joined Trump for Tuesday’s announcement at the 116-year-old cancer center.

YOU MAY BE INTERESTED IN

As NCI and NIH funding is being deliberated in Congress, this year’s 2025 AACR Cancer Progress Report had an unequivocal message: With 20 new anticancer therapeutics, new uses for eight previously approved anticancer therapeutics, two new early detection tools, and several AI-powered diagnostics approved over the span of just one year, cancer research funding yields a good return on investment. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login